Jeff Craven April 27, 2023 CORRECTED May 4, 2023 // Editor’s Note: An earlier version of this article misstated the percentage of COVID-positive patients in the study population. BOSTON – Atogepant helped reduce the number of mean migraine days among adults with episodic migraine who failed multiple other oral migraine medications, according to findings from a study presented at the 2023 annual meeting of the...